Hanmi Pharm. Co. Ltd. v. The Controller General Of Patents And Designs

C.A.(COMM.IPD-PAT) 464/2022

The appellant, Hanmi Pharm. Co. Ltd., filed two interlocutory applications before the Delhi High Court. The court disposed of I.A. 12819/2022 as infructuous based on the counsel's submission. Furthermore, the application seeking leave to file additional documents (I.A. 12818/2022) was allowed.

Jurisdiction
India
Court
Delhi High Court - Orders
Case Number
C.A.(COMM.IPD-PAT) 464/2022
Judge(s)
Jyoti Singh

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Hanmi Pharm. Co. Ltd. vs The Controller General Of Patents And Designs is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent(T)OP(TM) No. 427 of 2023

E.Kiruthikavs(1)K.S.Moorthi Ram, (2)M.Maheshwari Partnership Firm M/S.Vishwak Garments, The Registrar of Trade Marks

The Madras High Court dismissed the petition filed by E.Kiruthika seeking to cancel the trademark registration 'VISHWAK' (No.2406200). The court noted that the trademark registration had expired on October 4, 2023, and since the long stop date for renewal had passed, the petition was deemed infructuous. This highlights the critical importance of timely action regarding trademark renewals to maintain legal rights.

patentCivil Suit No.562 of 2007

M.C.JayasinghvsMishra Dhatu Nigam Limited (Midhani)

M.C. Jayasingh filed a suit alleging infringement of his registered Patents and Designs concerning 'Custom Mega Prosthesis' (CMP), specialized medical implants used in limb salvage surgery. The plaintiff claimed unique features, such as pivotal hinge mechanisms and thrust bearing pads, provided superior articulation and durability to the prostheses. However, the court found that the plaintiff failed to establish actual infringement against the defendants, concluding that the evidence presented was insufficient to prove similarity in shape or configuration.

patentCS(COMM)No.407/2020; CS(COMM)No.410/2020; CS(COMM)No.411/2020

Astrazeneca AbvsEmcure Pharmaceuticals Limited

The plaintiffs, AstraZeneca, allege that the defendants are infringing their patents related to the compound 'Dapagliflozin', used for treating type-2 diabetes. The plaintiffs seek an injunction against the defendants for not seeking licenses for the patents.

patentCS(COMM) 747/2022, I.As. 24519/2023, 24520/2023 & 24521/2023

Busy Infotech Pvt LtdvsXpert Tricks Softwares & Ors.

This Delhi High Court order addresses an ongoing suit filed by Busy Infotech Pvt Ltd against various defendants for copyright infringement and trademark passing off related to its 'BUSY Software.' The court noted that previous interim injunctions were in place, and several pro-forma defendants had been discharged after providing undertakings. On December 8, 2023, the court directed the Plaintiff to file an updated memo of parties within one week before listing the matter again.

patentC.O.(COMM.IPD-PAT) 23/2025, I.A. 28473/2025 & I.A. 28474/2025

Moti Insecticides Private LimitedvsGsp Crop Science Limited & Anr.

Moti Insecticides Private Limited filed a petition seeking the revocation of Indian Patent IN 394568. The court issued notice to the respondents and directed them to file their reply within four weeks.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call